What are the rules for advertising and promotion of pharmaceuticals?

In North Carolina, the rules for advertising and promotion of pharmaceuticals must adhere to the North Carolina Drug Advertisement and Promotion Act. This Act was passed by the North Carolina legislature in 1978, and updated in 2003. Under the Act, any advertisement for a prescription drug must include accurate information about the product’s indications, contraindications, and warnings as outlined by the Federal Food, Drug, and Cosmetic Act (FDCA). This includes any claims made by advertisers or promoters about the effectiveness of the drug. In addition, pharmaceutical companies must provide a balanced representation of risks and benefits. They must also provide a statement of the method of action and the ingredients in the drug. This applies to both print and broadcast advertisements. The Act also prohibits promotion of drugs without sufficient clinical evidence of safety and efficacy. This includes promotion of unapproved uses of a drug, as well as advertising or promotion that is false, misleading, or deceptive. Violation of the Act can result in civil or criminal penalties. For instance, a company may be fined up to $10,000 per violation. Furthermore, any person or company distributing false or misleading material may be deemed guilty of a felony and be subject to a prison sentence. Adherence to the Act is essential for the safe and responsible promotion of prescription drugs in North Carolina. Companies that take part in prescription drug promotion must ensure that their advertisements comply with the North Carolina Drug Advertisement and Promotion Act.

What are the rules for advertising and promotion of pharmaceuticals?

Related FAQs

Related Blog Posts